Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 2/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6358822 | 0.93 | ROCK2 (0.47) | CHRNB2CHRNA4 | |
| SCHEMBL7934123 | 0.85 | CHRNB2 (0.46) | CHRNB2CHRNA4CYP1A2CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL2366855 | 0.84 | CHRNB2 (0.45) | CHRNB2CHRNA4CYP1A2CYP3A4TSHR | |
| SCHEMBL3555696 | 0.79 | L3MBTL1 (0.42) | CYP1A2TSHRMEN1RECQLKMT2A | |
| SCHEMBL23561114 | 0.77 | HTR2C (0.49) | ALDH1A1KDM4EHTR2C | |
| SCHEMBL13035395 | 0.76 | TSHR (0.57) | TSHRMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL31652256 | 0.76 | CHRNB2 (0.42) | CHRNB2CHRNA4ALDH1A1HPGDKDM4E | |
| SCHEMBL14083432 | 0.75 | KMT2A (0.42) | CYP1A2MEN1KMT2AALDH1A1HPGD | |
| SCHEMBL14107789 | 0.75 | KMT2A (0.51) | CYP1A2TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL9014675 | 0.74 | ADRB1 (0.49) | CYP1A2CYP3A4TSHRMEN1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343101-A | Method for preparing antiviral nucleotide analogues | 吉利德科学公司 | 2024-01-05 | — | — | CN | claimed |
| EP-4636010-A1 | IMPROVED COMPOSITIONS FOR SELF-BLOWING NON-ISOCYANATE POLYURETHANE FOAMS | Université de Liège (BE) | 2025-10-22 | — | — | EP | disclosed |
| EP-4606804-A1 | METHOD FOR THE PREPARATION OF OXYGEN SUBSTITUTED CLOSO-CARBORATES | beeOLED GmbH (DE) | 2025-08-27 | — | — | EP | disclosed |
| EP-4591935-A2 | METHODS FOR THE PREPARATION OF RIBOSIDES | Gilead Sciences, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-113549120-B | Method for preparing ribonucleoside | 吉利德科学公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-4036099-B1 | METHODS FOR THE PREPARATION OF RIBOSIDES | GILEAD SCIENCES INC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-12139583-B2 | Resin molding | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-11-12 | — | — | US | disclosed |
| CN-118812607-A | Method for preparing ribonucleoside | 吉利德科学公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-117545785-A | Biodegradable graft polymers | 巴斯夫欧洲公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117500860-A | Polyalkylene oxide polymers, their preparation and use | 巴斯夫欧洲公司 | 2024-02-02 | — | — | CN | disclosed |
| US-5382661-A | Useful in treating spinal trauma, head injury, subarachnoid hemorrhage | THE UPJOHN COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| US-5380840-A | Treating spinal trauma, head injury, subarachnoid hemorrhage; reduced side effects | THE UPJOHN COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| US-5380839-A | Antitumor agents, antisecretory agents, enzyme inhibitors or antiasthmatics | THE UPJOHN COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| US-5380841-A | Steroids as antiinflammatory agents | THE UPJOHN COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| US-5322943-A | As substituents on steroids are useful as pharmaceutical agents for treating a number of conditions | THE UPJOHN COMPANY (US) | 1994-06-21 | — | — | US | disclosed |
| US-5268477-A | Containing a pyrrolidine or pyridine ring structure | THE UPJOHN COMPANY (US) | 1993-12-07 | — | — | US | disclosed |
| US-5099019-A | Central nervous system steroid derivative drugs | UPJOHN COMPANY (US) | 1992-03-24 | — | — | US | disclosed |
| EP-0263213-A1 | C20 Through C26 amino steroids | THE UPJOHN COMPANY (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0238545-A1 | C 20? THROUGH C 26? AMINO STEROIDS. | UPJOHN CO (US) | 1987-09-30 | — | — | EP | disclosed |
| WO-1987001706-A2 | C20 THROUGH C26 AMINO STEROIDS | THE UPJOHN COMPANY (US) | 1987-03-26 | — | — | WO | disclosed |